- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01542905
Stress Relief Effect of Korean Red Ginseng
May 23, 2015 updated by: In Kyoon Lyoo, MD, PhD, MMS, Seoul National University Hospital
Effects of Korean Red Ginseng on Stress Relief and Cognitive and Mental Function Enhancement Using Neuroimaging: Double-Blind, Randomized, Placebo-Controlled Clinical Trial
The purpose of this study is to examine clinical and neuropsychiatric effects of Korean Red Ginseng and examine changes in brain structure, function and metabolites.
A total of 60 healthy volunteers will be recruited and will be assigned to either Korean Red Ginseng group or placebo group.
Individuals will be examined through clinical assessment, neuropsychological function tests and neuroimaging.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ages between 18~65
Exclusion Criteria:
- Current or past medical history, medical illnesses that are detected during clinical and physical evaluations
- Current Axis 1 diagnosis or past history of schizophrenia, bipolar, or psychotic disorders assessed by SCID-IV
- Current diagnosis of substance abuse assessed by SCID-IV
- Taking or have taken psychiatric medication in the past 2 months
- Head trauma accompanied by loss of consciousness or seizure
- IQ 80 or below
- Planning pregnancy, currently pregnant, or breastfeeding
- Claustrophobia or other fMRI incompatible factors such as pace makers
- Taking drugs, including over the counter drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Placebo Capsule (1g/day) for 8 Weeks
|
|
Experimental: Korean Red Ginseng
|
Korean Red Ginseng Capsule (1g/day) for 8 Weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline in Stress Scores at 8 Weeks
Time Frame: Baseline and 8 Weeks
|
Baseline and 8 Weeks
|
|
Change from Baseline in Stress Scores at 4 Weeks
Time Frame: Baseline and 4 Weeks
|
Baseline and 4 Weeks
|
|
Change from Baseline in Stress Scores at 1 Week
Time Frame: Baseline and 1 Week
|
Baseline and 1 Week
|
|
Change from Baseline in Neurocognitive Function at 8 Weeks
Time Frame: Baseline and 8 Weeks
|
Baseline and 8 Weeks
|
|
Change from Baseline in Brain Function, Chemistry, and Structure Measured Using Magnetic Resonance Imaging at 8 Weeks
Time Frame: Baseline and 8 Weeks
|
Baseline and 8 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Fatigue Scores at 8 Weeks
Time Frame: Baseline and 8 Weeks
|
Baseline and 8 Weeks
|
|
Change in Fatigue Scores at 4 Weeks
Time Frame: Baseline and 4 Weeks
|
Baseline and 4 Weeks
|
|
Change in Fatigue Scores at 1 Week
Time Frame: Baseline and 1 Week
|
Baseline and 1 Week
|
|
Change in Depressive Scores at 8 Weeks
Time Frame: Baseline and 8 Weeks
|
Baseline and 8 Weeks
|
|
Change in Depressive Scores at 4 Weeks
Time Frame: Baseline and 4 Weeks
|
Baseline and 4 Weeks
|
|
Change in Depressive Scores at 1 Week
Time Frame: Baseline and 1 Week
|
Baseline and 1 Week
|
|
Change in Anxiety Scores at 8 Weeks
Time Frame: Baseline and 8 Weeks
|
Baseline and 8 Weeks
|
|
Change in Anxiety Scores at 4 Weeks
Time Frame: Baseline and 4 Weeks
|
Baseline and 4 Weeks
|
|
Change in Anxiety Scores at 1 Week
Time Frame: Baseline and 1 Week
|
Baseline and 1 Week
|
|
Number of Participants Who Experienced Adverse Events
Time Frame: Week 1
|
Week 1
|
|
Number of Participants Who Experienced Adverse Events
Time Frame: Week 4
|
Week 4
|
|
Number of Participants Who Experienced Adverse Events
Time Frame: Week 8
|
Week 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Primary Completion (Actual)
April 1, 2011
Study Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
February 26, 2012
First Submitted That Met QC Criteria
February 26, 2012
First Posted (Estimate)
March 2, 2012
Study Record Updates
Last Update Posted (Estimate)
May 27, 2015
Last Update Submitted That Met QC Criteria
May 23, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- KG2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Relief
-
Ain Shams UniversityCompleted
-
Aalborg UniversityCompleted
-
Assiut UniversityCompleted
-
Assiut UniversityCompleted
-
Wake Forest University Health SciencesCompleted
-
IRCCS Burlo GarofoloCompleted
-
Western Galilee Hospital-NahariyaWithdrawn
-
Assiut UniversityCompleted
Clinical Trials on Korean Red Ginseng
-
Unity Health TorontoHeart and Stroke Foundation of CanadaCompletedHypertension | Blood Pressure | Endothelial FunctionCanada
-
Shanghai Jiao Tong University School of MedicineRenJi Hospital; Beijing Obstetrics and Gynecology Hospital; Foshan Fuxing Changcheng... and other collaboratorsCompletedAntioxidative Stress | Healthy AgeingChina
-
The Korean Society of GinsengCompleted
-
The Korean Society of GinsengCompleted
-
Daegu Catholic University Medical CenterThe Korean Society of GinsengCompletedHypertensionKorea, Republic of
-
Unity Health TorontoCompletedMetabolic Syndrome | Type 2 DiabetesCanada
-
Korea Ginseng CorporationNutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedCardiovascular Diseases | Platelet Aggregation | Vasodilation | Blood Pressure DisordersUnited States
-
Korea UniversityThe Korean Society of GinsengCompletedMajor Depressive DisorderKorea, Republic of
-
Hanyang UniversityThe Korean Society of GinsengUnknownRheumatic Diseases | Sjögren's Syndrome | Korean Red GinsengKorea, Republic of